Platinum (II)-coordinated Portulaca oleracea polysaccharides as metal-drug based polymers for anticancer study
Source abstract
Abstract
Novel polysaccharide-platinum conjugated polymers bearing alendronate on Portulaca oleracea polysaccharides (PPS) were designed and synthesized. Their chemical structures and properties were characterized by Fourier transform infrared spectroscopy (FT-IR), 1H NMR and 31P NMR spectroscopy, Thermogravimetric analysis (TGA), X-ray powder diffraction (XRD), UV-vis spectrophotometer (UV-vis) and other analysis methods. The results demonstrated that alendronate can be used as the linker of Portulaca oleracea polysaccharides and platinum compounds. Portulaca oleracea polysaccharides-alendronate (PPS-ALN) conjugates exhibited stronger antioxidant ability than PPS. The cytotoxicity assay to cancer cells was tested in vitro, and the Portulaca oleracea polysaccharides-alendronate-platinum (PPS-ALN-Pt) conjugates strongly inhibited the proliferation of cancer cells than PPS and PPS-ALN. The evaluation of complexes affinity toward supercoiled plasmid DNA, displayed a high DNA interaction. Interestingly, the platinum conjugates displayed immunological competence in HeLa cells by cellular immunofluorescence assay. Besides, the cellular platinum accumulation of PPS-ALN-Pt conjugates was higher than that of cisplatin in HeLa cells, implying that the polysaccharide-platinum conjugated polymers might have a synergistically therapeutic application in metal anticancer drug delivery.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Antioxidants, Aging, Portulaca oleracea · biodegradable polymer synthesis and properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (58)
Show source-provided references
1. The resurgence of platinum-based cancer chemotherapy10.1038/nrc2167 ↗
2. The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs10.1021/acs.chemrev.5b00597 ↗
3. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(l-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy10.1016/j.jconrel.2014.12.022 ↗
4. Platinum(II) coordination compounds with 4′-pyridyl functionalized 2,2′:6′,2″-terpyridines as an alternative to enhanced chemotherapy efficacy and reduced side-effects10.1016/j.jinorgbio.2019.110809 ↗
5. Synthesis and properties of a new micellar polyphosphazene-platinum(II) conjugate drug10.1016/j.jinorgbio.2014.06.014 ↗
6. Development and characterization of a novel drug nanocarrier for oral delivery, based on self-assembled β-casein micelles10.1016/j.jconrel.2012.01.004 ↗
7. A thermosensitive drug delivery system prepared by blend electrospinning10.1016/j.colsurfb.2017.07.058 ↗
8. Tumor microenvironment-induced structure changing drug/gene delivery system for overcoming delivery-associated challenges10.1016/j.jconrel.2020.04.026 ↗
9. Recent advances in targeted drug delivery approaches using dendritic polymers10.1039/C4BM00351A ↗
10. Dual-responsive nanoparticles based on chitosan for enhanced breast cancer therapy10.1016/j.carbpol.2019.05.081 ↗
11. Organometallic gold(III) complexes similar to tetrahydroisoquinoline induce ER-stress-mediated apoptosis and pro-Death autophagy in A549 cancer cells10.1021/acs.jmedchem.7b01694 ↗
12. Application of glycosylation in targeted drug delivery10.1016/j.ejmech.2019.111612 ↗
13. Recent progress in polymer-based platinum drug delivery systems10.1016/j.progpolymsci.2018.07.004 ↗
14. Magnetic nanoparticle-loaded alginate beads for local micro-actuation of in vitro tissue constructs10.1016/j.colsurfb.2017.08.062 ↗
15. Recent advances in theranostic polymeric nanoparticles for cancer treatment: a review10.1016/j.ijpharm.2020.119314 ↗
16. Engineering of pectin-dopamine nano-conjugates for carrying ruthenium complex: a potential tool for biomedical applications10.1016/j.jinorgbio.2018.11.016 ↗
17. Hyaluronan delivery by polymer demixing in polysaccharide-based hydrogels and membranes for biomedical applications10.1016/j.carbpol.2016.03.088 ↗
18. Hyaluronan based materials with catanionic sugar-derived surfactants as drug delivery systems10.1016/j.colsurfb.2018.01.037 ↗
19. Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy10.1016/j.colsurfb.2019.110373 ↗
20. Hybrid micelles based on Pt (IV) polymeric prodrug and TPGS for the enhanced cytotoxicity in drug-resistant lung cancer cells10.1016/j.colsurfb.2020.111256 ↗
21. Delivery of platinum(IV) drug to subcutaneous tumor and lung metastasis using bradykinin-potentiating peptide-decorated chitosan nanoparticles10.1016/j.biomaterials.2014.04.016 ↗
22. Polymer “ruthenium-cyclopentadienyl” conjugates-New emerging anti-cancer drugs10.1016/j.ejmech.2019.02.061 ↗
23. Portulene, a new diterpene from Portulaca oleracea L10.1080/10286020802320590 ↗
24. Antioxidant activities of novel small-molecule polysaccharide fractions purified from Portulaca oleracea L10.1007/s10068-014-0278-y ↗
25. Characterization of structures and antiviral effects of polysaccharides from Portulaca oleracea l10.1248/cpb.58.507 ↗
26. Acidic polysaccharide complexes from purslane, silver linden and lavender stimulate Peyer’s patch immune cells through innate and adaptive mechanisms10.1016/j.ijbiomac.2017.07.095 ↗
27. Detection of antifungal activity in Portulaca oleracea by a single-cell bioassay system10.1002/1099-1573(200008)14:5<329::AID-PTR581>3.0.CO;2-5 ↗
28. Purification and characterization of an antitumor polysaccharide from Portulaca oleracea L10.1016/j.carbpol.2012.11.107 ↗
29. Antitumor activity of Portulaca oleracea L. Polysaccharides against cervical carcinoma in vitro and in vivo10.1016/j.carbpol.2013.04.023 ↗
30. Evaluation of antioxidant and immuno-enhancing activities of Purslane polysaccharides in gastric cancer rats10.1016/j.ijbiomac.2014.04.038 ↗
31. Purification and characterization of an antitumor polysaccharide from Portulaca oleracea L10.1016/j.carbpol.2012.11.107 ↗
32. Insight on the periodate oxidation of dextran and its structural vicissitudes10.1016/j.polymer.2010.11.058 ↗
33. Water soluble antioxidant dextran-quercetin conjugate with potential anticancer properties10.1002/mabi.201700239 ↗
34. Nonfouling characteristics of dextran-containing surfaces10.1021/la061064b ↗
35. Drug binding rate regulates the properties of polysaccharide prodrugs10.1039/C6TB00991C ↗
36. Schiff base bond-linked polysaccharide-doxorubicin conjugate for upregulated cancer therapy10.1016/j.msec.2017.03.201 ↗
37. Cisplatin-stitched polysaccharide vesicles for synergistic Cancer therapy of triple antagonistic drugs10.1021/acs.biomac.6b01411 ↗
38. Preparation, characterization and bioactivities of derivatives of an exopolysaccharide from Lachnum10.1016/j.carbpol.2014.10.046 ↗
39. Phosphorylation and antiaging activity of polysaccharide from Trichosanthes peel10.1016/j.jfda.2016.12.013 ↗
40. Antioxidant activity applying an improved ABTS radical cation decolorization assay10.1016/S0891-5849(98)00315-3 ↗
41. Extraction, derivatization and antioxidant activity of bitter gourd polysaccharide10.1016/j.ijbiomac.2019.08.239 ↗
42. The assembly and antitumor activity of lycium barbarum polysaccharide-platinum-based conjugates10.1016/j.jinorgbio.2020.111001 ↗
43. DNA/protein binding, DNA cleavage, cytotoxicity, superoxide radical scavenging and molecular docking studies of copper(II) complexes containing N-benzyl-N′-aryl-N′′-benzoylguanidine ligands10.1039/C4QI00234B ↗
44. ABHD5 blunts the sensitivity of colorectal cancer to fluorouracil via promoting autophagic uracil yield10.1038/s41467-019-08902-x ↗
45. Towards rational design of RAD51-targeting prodrugs: platinumIV-artesunate conjugates with enhanced cytotoxicity against BRCA-proficient ovarian and breast cancer cells10.1039/C8CC06576D ↗
46. Enhancing cytotoxicity of a monofunctional platinum complex via a Dual-DNA-Damage approach10.1021/acs.inorgchem.9b02033 ↗
47. Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition10.1038/nmat3922 ↗
48. Purification, structure, lipid lowering and liver protecting effects of polysaccharide from Lachnum YM28110.1016/j.carbpol.2013.07.014 ↗
49. Coordination self-assembly of platinum-bisphosphonate polymer-metal complex nanoparticles for cisplatin delivery and effective cancer therapy10.1039/C7NR02662E ↗
50. Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours10.1039/b919721d ↗
51. Reactions of platinum(II) aqua complexes. 2. Platinum-195 NMR study of reactions between the tetraaquaplatinum(II) cation and chloride, hydroxide, perchlorate, nitrate, sulfate, phosphate, and acetate10.1021/ic00190a017 ↗
52. Orange waste: a valuable carbohydrate source for the development of beads with enhanced adsorption properties for cationic dyes10.1016/j.carbpol.2016.10.019 ↗
53. Reconstitution properties of micellar casein powder: effects of composition and storage10.1016/j.idairyj.2011.05.004 ↗
54. Structural, thermal and rheological characterization of modified Dalbergia sissoo gum-A medicinal gum10.1016/j.ijbiomac.2015.12.001 ↗
55. Evaluation of free radicals scavenging and immunity-modulatory activities of Purslane polysaccharides10.1016/j.ijbiomac.2009.07.009 ↗
56. Biocompatible graphene oxide nanoparticle-based drug delivery platform for tumor microenvironment-responsive triggered release of doxorubicin10.1021/la502952f ↗
57. The ins and outs of calreticulin: from the ER lumen to the extracellular space10.1016/S0962-8924(01)01926-2 ↗
58. Immunogenic cancer cell death: a key-lock paradigm10.1016/j.coi.2008.05.007 ↗